supp.fit

Vitamin E and Beta-Carotene: study protocols

114 study groups took Vitamin E together with Beta-Carotene. These are the doses the studies gave. They are not a recommendation.

Vitamin E: what the research found →

Dose per serving from research: Vitamin E

83 study groups in 71 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 40% of 83 study groups.

Daily doseStudy groups
10 mg or less
2
10 mg to 25 mg
11
25 mg to 50 mg
33
50 mg to 100 mg
11
100 mg to 250 mg
8
250 mg to 500 mg
10
500 mg to 1 g
8

Dose per serving from research: Beta-Carotene

108 study groups in 85 studies say how much Beta-Carotene participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 53% of 108 study groups.

Daily doseStudy groups
5 mg or less
6
5 mg to 10 mg
28
10 mg to 25 mg
57
25 mg to 50 mg
17

Commonly used together

90 of 114 study groups took Vitamin E and Beta-Carotene with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin C
83
Zinc
29
Selenium
24
Vitamin A
8
Copper
6
Omega-3 Fatty Acids
3

114 study groups

Study
MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
1999 · antioxidant vitamin supplement · Men and women aged 40–80 at elevated risk of coronary heart disease death due to prior coronary heart disease, occlusive non-coronary arterial disease, diabetes mellitus, or treated hypertension
600 mg20 mg5 years—
The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers
1999 · both AT and BC · middle-aged male smokers
50 mg20 mg——
Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers
2000 · alpha-tocopherol and beta-carotene · Men aged 50 to 69 who smoked cigarettes and had no history of stroke
50 mg20 mg6 years—
Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
2000 · alpha tocopherol and beta carotene · Men aged 50–69 who smoked and were included in the high-risk-for-stroke subgroup analysis
50 mg20 mg6 years—
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
400 IU15 mg8 years—
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants alone · Adults aged 55–81 years with age-related macular degeneration categories 1–4 or other AREDS ocular eligibility; participants in AMD categories 2–4 were eligible for this arm, and category 1 participants could also receive antioxidants
400 IU15 mg339 weeks—
Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study
2004 · alpha-tocopherol plus beta-carotene · men aged 50–69 who smoked
50 mg20 mg8 years—
Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients
2006 · supplement arm · Head and neck cancer patients treated by radiation therapy
400 IU30 mg——
Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial
2007 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 years, free of cancer at baseline
50 mg20 mg2227 days—
Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake
2008 · Vitamin E and beta-carotene · Males aged 50–69 years who smoked at baseline and had no tuberculosis diagnosis before randomisation
50 mg20 mg2228 days—
Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C
2009 · vitamin E + β-carotene · men aged 50–69 years who smoked at least 5 cigarettes per day
50 mg20 mg8 years—
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial
2009 · Factor D · Adults in Linxian, China; age and sex details not given
30 mg15 mg313 weeks—
Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival
2009 · α-tocopherol and β-carotene · Caucasian male smokers aged 50–69 years; prostate cancer cases were analysed in this report
50 mg20 mg8 years—
Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis
2013 · combined β-carotene/α-tocopherol · Finnish male smokers aged 50–69
50 mg20 mg2227 days—
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
400 IU15 mg339 weeks—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
400 IU15 mg9 years—
Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study
2014 · α-tocopherol and β-carotene · Finnish male smokers aged 50–69 at baseline without self-reported cirrhosis
50 mg20 mg2922 days—
Vitamin E administration may decrease the incidence of pneumonia in elderly males
2016 · AT + BC (vitamin E + β-carotene) · Finnish males aged 50–69 at entry who smoked at least 5 cigarettes per day and started smoking at age 21 or older; the analysis subgroup included men who smoked 5–19 cigarettes per day and exercised at leisure at baseline
50 mg20 mg8 years—
The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
2020 · α-Tocopherol and β-carotene (AT + BC) · Male smokers aged 50–69 years who smoked at least 5 cigarettes per day at entry
50 mg20 mg2227 days—
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study
1995 · beta-carotene and alpha-tocopherol · Male cigarette smokers aged 50–69 years
50 mg20 mg8 years—
Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer
1993 · retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis
11.4 mg40 mg87 weeks—
Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial
1996 · alpha tocopherol plus beta carotene group · Men aged 50–69 who smoked and were free of known coronary heart disease at baseline
50 mg20 mg1716 days—
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance
1996 · alpha-tocopherol and beta-carotene · Men aged 50–69 years who smoked at least five cigarettes daily
50 mg20 mg2227 days—
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial
1997 · vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C was common at baseline
15 mg6 mg2 years—
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial
1998 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 years
50 mg20 mg2228 days—
"The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants
1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition
30 mg6 mg8 years—
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
400 IU15 mg8 years—
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility
400 IU15 mg339 weeks—
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals
2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population
30 mg6 mg2739 days—
Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?
2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
30 mg6 mg2739 days—
[The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health]
2006 · antioxidant supplementation · Middle-aged adults in the general population
30 mg6 mg2738 days—
Antioxidant supplementation increases the risk of skin cancers in women but not in men
2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial
30 mg6 mg2738 days—
Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study
2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years
30 mg6 mg2738 days—
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
400 IU15 mg339 weeks—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
400 IU15 mg9 years—
Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer
1993 · riboflavin plus retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis
11.4 mg40 mg87 weeks—
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial
1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline
15 mg6 mg2 years—
Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants
1998 · active medication · Adults with colorectal polyps; age range and sex not stated
75 mg15 mg3 years—
Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements
1998 · supplementation group · Amateur cyclists; age and sex not reported; no condition stated
75 mg15 mg90 days12
The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial
1999 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 with intermittent claudication
50 mg20 mg193 weeks—
Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans
2000 · Carotenoid supplement plus vitamin E · Healthy volunteers
335 mg25 mg12 weeks—
The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract
2002 · vitamin group · Adult American and English outpatients with early age-related cataract
600 mg18 mg3 years—
Physical activity and the common cold in men administered vitamin E and beta-carotene
2003 · Vitamin E and beta-carotene · Men aged 50–69 who smoked; common-cold risk was assessed in physically active subgroups
50 mg20 mg2227 days—
Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients
2005 · supplement arm · Head and neck cancer patients receiving radiation therapy; age and sex not stated
400 IU30 mg3 years—
Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone
1998 · supplement group · Mexico City street workers exposed to high ozone levels; age and sex not stated
75 mg15 mg26 weeks—
Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study
2006 · Colostrum + Micronutrients · Healthy, non-smoking men and women aged 40–80 years
200 mg—10 weeks35
[Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis]
2004 · Karinat · Patients with chronic multifocal atrophic gastritis
10 mg5 mg26 weeks34
[Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease]
2004 · Karinat · Patients with benign breast disease, including mastopathy
10 mg5 mg26 weeks33
Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study
2006 · Micronutrients · Healthy, non-smoking men and women aged 40–80 years
200 mg—10 weeks31
Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training
2011 · Nutrients (active treatment) · Normally hearing Swedish military personnel, officers and military academy trainees, ages 18 and older, undergoing weapons training
305 mg18 mg2 days31
French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial
2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study
30 mg6 mg2922 days—
Combination oral antioxidant supplementation reduces blood pressure
1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints.
600 mg30 mg8 weeks—
Supplementation with antioxidants prior to bone marrow transplantation
1997 · BMT(+) · Bone marrow transplant patients receiving conditioning therapy
825 mg45 mg3 weeks16
Accumulation and interactions of beta-carotene and alpha-tocopherol in patients with adenomatous polyps
2002 · combination BC/VE · Volunteers with colonic adenomatous polyps; age and sex not reported
400 IU25,000 IU43 days—
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
1996 · Treatment 1 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified
600 mg18 mg7 days—
Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network
1996 · V (vitamins) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized
15 mg6 mg26 weeks—
Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters
1997 · vitamin group · Hospitalized adults older than 65 years; baseline vitamin C deficiency was common
15 mg6 mg2 years—
Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX
1997 · vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care
15 mg6 mg1 year—
[Effects of vitamins E, C and beta-carotene on DNA damage]
1999 · trial group · Healthy men aged 50–59 years
280 mg25 mg20 weeks50
Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial
2021 · Liposomal group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis
200 IU4 mg90 days25
Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial
2021 · MCT group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis
200 IU4 mg90 days25
Antioxidant vitamins and low-density-lipoprotein oxidation
1993 · antioxidant supplementation · Adults; ages and health conditions not stated
200 mg18 mg26 weeks22
Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial
1992 · active treatment · Patients with recurrent non-gallstone pancreatitis
270 IU9,000 IU10 weeks20
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men
400 mg17.2 mg1 day15
Antioxidant supplementation enhances neutrophil oxidative burst in trained runners following prolonged exercise
2003 · antioxidant vitamin supplement · Healthy trained endurance runners; 6 men and 6 women, mean age 30.1 years
90 mg18 mg7 days12
Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation
1993 · combined antioxidant therapy · adult male subjects; age and health condition not specified
800 IU30 mg90 days12
Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients
2005 · antioxidant supplementation phase · renal transplant recipients taking cyclosporin A; age and sex not reported
400 IU6 mg26 weeks10
Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study
2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population
30 mg6 mg2 years—
Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes
2002 · antioxidant-supplemented group · Sportsmen; age and health condition not specified
500 mg30 mg90 days—
Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function
2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified
200 mg25 mg8 weeks—
Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation
2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation
30 mg6 mg3 weeks—
Antioxidant diet supplementation influences blood iron status in endurance athletes
2004 · antioxidant supplemented · Amateur trained male endurance athletes
500 mg30 mg90 days—
Response of blood cell antioxidant enzyme defences to antioxidant diet supplementation and to intense exercise
2006 · antioxidant supplemented · Amateur trained male athletes; age and health condition not specified
500 mg30 mg90 days—
Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults
2006 · overweight adults receiving antioxidant treatment · overweight adults aged 18–30 years
800 IU10 mg8 weeks—
Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults
2006 · normal-weight adults receiving antioxidant treatment · normal-weight adults aged 18–30 years
800 IU10 mg8 weeks—
Multivitamin-mineral supplementation prevents lipid peroxidation during "the Marathon des Sables"
2007 · Supplemented group · Athletes participating in the Marathon des Sables; age and sex not specified
24 mg4.8 mg4 weeks—
Antioxidant diet supplementation enhances aerobic performance in amateur sportsmen
2007 · antioxidant-supplemented group · Amateur male athletes; age and health condition not stated
500 mg30 mg90 days—
Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women
2009 · multivitamins including vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum
30 mg30 mg——
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 1 · Adults aged 60–75 years; elderly participants
200 mg16.7 mg16 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 2 · Adults aged 60–75 years; elderly participants
200 mg8.4 mg16 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 3 · Adults aged 60–75 years; elderly participants
200 mg5.6 mg16 weeks—
Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults
2009 · Normal-weight antioxidant-treated (N-AOX) · Apparently healthy men and women aged 18–30 years with BMI <25 kg/m²
800 IU10 mg8 weeks—
Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults
2009 · Overweight antioxidant-treated (O-AOX) · Apparently healthy men and women aged 18–30 years with BMI ≥25 kg/m²
800 IU10 mg8 weeks—
Multinutrient-fortified juices improve vitamin D and vitamin E status in children: a randomized controlled trial
2014 · CaDEA · Children aged approximately 8 years
12 IU2,000 IU12 weeks—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants only · Adults aged 55–80 with early or more advanced age-related macular degeneration
400 IU15 mg5 years—
Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise
1993 · antioxidant vitamin group · Young healthy males, mean age 25.0 years
592 mg30 mg6 weeks—
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
1996 · Treatment 2 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified
75 mg15 mg7 days—
Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network
1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized
15 mg6 mg26 weeks—
Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation
1997 · beta-carotene plus alpha-tocopherol · Male medical students; age not reported; no condition reported
400 IU30 mg10 weeks—
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease
1997 · mid-dose · Patients with established cardiovascular disease
400 IU12 mg12 weeks—
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease
1997 · high dose · Patients with established cardiovascular disease
800 IU24 mg12 weeks—
Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters
1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common
15 mg6 mg2 years—
Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX
1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care
15 mg6 mg1 year—
Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects
1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years
30 mg6 mg26 weeks—
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
1998 · antioxidants without n-3 fatty acids · adult male smokers with hyperlipidaemia
75 mg15 mg6 weeks—
Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)
1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated
400 mg25 mg4 weeks63
Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk
2004 · antioxidant-supplemented group · Middle-aged men: myocardial infarction survivors younger than 50 and healthy controls
100 mg6 mg12 weeks53
[Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children]
2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area
100 mg1 mg8 weeks41
Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status
1991 · antioxidant-supplemented men · Men with low antioxidant status
300 mg27 mg150 days39
Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial
1994 · supplemented group · Healthy men aged 30–58 years who smoked 15–40 cigarettes per day
200 mg30 mg90 days20
Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training
1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m
400 IU20,000 IU2 weeks—
Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study
2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
30 mg6 mg2738 days—
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration
2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration
400 IU15 mg2433 days—
Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial
2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified
800 mg24 mg120 days—
Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise
2011 · LCPUFA plus antioxidant mixture · Judoists; age and sex not reported; no diagnosed condition stated
30 mg6 mg6 weeks—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration
400 IU15 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
400 IU15 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
400 IU15 mg5 years—
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · antioxidants · male smokers with combined hyperlipidemia
75 mg15 mg6 weeks—
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · omega-3 FAs and antioxidants · male smokers with combined hyperlipidemia
75 mg15 mg6 weeks—
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
1998 · n-3 fatty acids with antioxidants · adult male smokers with hyperlipidaemia
75 mg15 mg6 weeks—
Supplementation with antioxidants prior to bone marrow transplantation
1997 · Healthy control group · Healthy controls
825 mg45 mg3 weeks10
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration
2007 · antioxidants · Adults aged 55–80 with age-related macular degeneration
400 IU15 mg2433 days—
Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk
2009 · β-carotene plus vitamin E group · Men aged 50–69 years in southwestern Finland who smoked at least five cigarettes per day
50 mg20 mg2228 days—